IFNAR2 gene related symptoms and diseases
All the information presented here about the IFNAR2 gene and its related diseases, symptoms, and test panels has been aggregated from the following public sources: OMIM,HGNC,NCBIGENE,ORPHANET, Mendelian Rare Disease Search Engine.
Top 5 symptoms and clinical features associated to IFNAR2 gene
| Symptoms // Phenotype | % Cases |
|---|---|
| Fever | Very Common - Between 80% and 100% cases |
| Hepatitis | Very Common - Between 80% and 100% cases |
| Pain | Uncommon - Between 30% and 50% cases |
| Dark urine | Uncommon - Between 30% and 50% cases |
| Hyponatremia | Uncommon - Between 30% and 50% cases |
Other less frequent symptoms and clinical features
Patients with IFNAR2 gene alterations may also develop some of the following symptoms and phenotypes:Not very common - Between 30% and 50% cases
- Encephalitis
- Lymphopenia
- Skin rash
- Seizures
- Fulminant hepatitis
- Acute hepatitis
- Membranous nephropathy
- Chronic infection
And 13 more phenotypes, you can get all of them using our tools for rare diseases.
Rare diseases associated to IFNAR2 gene
Here you will find a list of rare diseases related to the IFNAR2. You can also use our tool to get a more accurate diagnosis based on your current symptoms.
HEPATITIS B VIRUS, SUSCEPTIBILITY TO
Alternate names
HEPATITIS B VIRUS, SUSCEPTIBILITY TO Is also known as hbv, susceptibility to
Description
HBV is a DNA virus that enters the liver via the bloodstream, and replication occurs only in liver tissue. Transmission occurs by percutaneous or mucosal exposure to infected blood or other body fluids. Approximately one third of all cases of cirrhosis and half of all cases of hepatocellular carcinoma (HCC ) can be attributed to chronic HBV infection. Worldwide, 2 billion people have been infected with HBV, 360 million have chronic infection, and 600,000 die each year from HBV-related liver disease or HCC. However, there is marked geographic variability in HBV prevalence, with chronic infection affecting less than 2% of the populations of North America and western and northern Europe; between 2 and 7% of the populations of eastern and central Europe, the Amazon basin, the Middle East, and the Indian subcontinent; and more than 8% of the populations of Asia, sub-Saharan Africa, and the Pacific (Seeff and Hoofnagle, 2006; Shepard et al., 2006).
Most common symptoms of HEPATITIS B VIRUS, SUSCEPTIBILITY TO
- Pain
- Hepatomegaly
- Fever
- Vomiting
- Splenomegaly
More info about HEPATITIS B VIRUS, SUSCEPTIBILITY TO
SOURCES: OMIM
PRIMARY IMMUNODEFICIENCY WITH POST-MEASLES-MUMPS-RUBELLA VACCINE VIRAL INFECTION
Alternate names
PRIMARY IMMUNODEFICIENCY WITH POST-MEASLES-MUMPS-RUBELLA VACCINE VIRAL INFECTION Is also known as primary immunodeficiency with post-mmr vaccine viral infection
Description
Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection is a rare primary immunodeficiency due to a defect in innate immunity disorder characterized by selective susceptibility to viral infections, particularly after systemic challenge with live viral vaccines, such as the measles, mumps and rubella (MMR) vaccine. Patients present severe, potentially fatal, manifestations to viral illness, including encephalitis, hepatitis and pneumonitis.
Most common symptoms of PRIMARY IMMUNODEFICIENCY WITH POST-MEASLES-MUMPS-RUBELLA VACCINE VIRAL INFECTION
- Seizures
- Fever
- Skin rash
- Hepatitis
- Lymphopenia
More info about PRIMARY IMMUNODEFICIENCY WITH POST-MEASLES-MUMPS-RUBELLA VACCINE VIRAL INFECTION
Search interest in IFNAR2
Potential gene panels for IFNAR2 gene
IFNAR2 Panel
United States.
By Fulgent Genetics Fulgent Genetics
This panel specifically test the IFNAR2 gene.
More info about this panel United States.
Primary Immunodeficiency Panel Panel
Finland.
By Blueprint Genetics Primary Immunodeficiency Panel that also includes the following genes: RMRP RORC CFB BLM SH2D1A SLC7A7 SMARCAL1 SMARCD2 SRP72 BTK
More info about this panel Finland.
Tempus xT assay Panel
United States.
By Tempus Labs, Inc. Tempus xT assay that also includes the following genes: BCL6 RIT1 BCL7A BCR ROS1 RPL5 RPS15 RPS6KB1 RUNX1 RXRA
More info about this panel United States.
If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like PCARE PDSS2 ALDH1A3 UNC13A PNPLA1 KCNAB2 IRS2